Illán-Cabeza Nuria A, García-García Antonio R, Moreno-Carretero Miguel N, Martínez-Martos José M, Ramírez-Expósito María J
Departamento de Química Inorgánica y Orgánica, Universidad de Jaén, 23071 Jaén, Spain.
J Inorg Biochem. 2005 Aug;99(8):1637-45. doi: 10.1016/j.jinorgbio.2005.05.003.
New complexes of rhenium(I) with some 5-nitrosopyrimidines with general formula [ReCl(CO)3L] have been prepared and characterized by elemental analysis, conductivity measurements, IR and 1H, 13C and 15N NMR spectroscopic methods. The complexes appear to be monomeric and the pyrimidine ligands act in a neutral form. The structure of [ReCl(CO)3(DANU)].CH3CN has been solved by X-ray diffraction. The coordination environment around the Re(I) may be described as a distorted octahedron in which the ligand behaves in a bidentate fashion through N5 and O4 atoms, making a five-membered chelate ring. The coordination sphere is completed with three carbonyl groups in fac-arrangement and one chlorine atom. The evaluation of the antiproliferative behavior against five human tumor cell lines (human breast cancer MCF-7 and EVSA-T, human neuroblastoma NB69, human glioma H4 and human bladder carcinoma cell line ECV) suggested a modulator behavior of cell growth at low concentrations due to their estrogenic-like characteristics.
已制备出通式为[ReCl(CO)₃L]的铼(I)与一些5-亚硝基嘧啶形成的新型配合物,并通过元素分析、电导率测量、红外光谱以及¹H、¹³C和¹⁵N核磁共振光谱方法对其进行了表征。这些配合物似乎为单体,嘧啶配体以中性形式起作用。已通过X射线衍射解析了[ReCl(CO)₃(DANU)].CH₃CN的结构。Re(I)周围的配位环境可描述为一个扭曲的八面体,其中配体通过N₅和O₄原子以双齿方式配位,形成一个五元螯合环。配位球由三个呈面式排列的羰基和一个氯原子构成。针对五种人类肿瘤细胞系(人乳腺癌MCF-7和EVSA-T、人神经母细胞瘤NB69、人胶质瘤H4和人膀胱癌细胞系ECV)的抗增殖行为评估表明,由于其类似雌激素的特性,这些配合物在低浓度下具有调节细胞生长的行为。